These results have deepened the understanding of the driving mechanisms of lncRNAs in the development, progression, and chemotherapy resistance of HCC and provided greater insight into the importance of DUXAP8 in HCC progression, which may help provide ideas for finding new prognostic indicators and therapeutic targets for HCC patients. Here, DUXAP8 is linked to hepatocellular carcinoma.